See Why the Alaska Permanent Fund is Smiling
Posted on 06/30/2015
The Alaska Permanent Fund Corporation (APFC) took a calculated risk and bought in early in Seattle-based Juno Therapeutics. Financially backing pharmaceutical firms in the early-stage process is risky. The wealth fund rode its investment in Juno Therapeutics far beyond the pharmaceutical company’s initial public offering (IPO). On the morning of June 30th, Juno Therapeutics’ shares […]
- Alaska Permanent Fund Corporation
- cancer
- Celgene
- Deals
- direct investing
- Juno Therapeutics
- pharmaceuticals
- treatments
